Treatment of invasive candidiasis in the elderly: a review
Open Access
- 1 September 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Clinical Interventions in Aging
- Vol. 8, 1199-208
- https://doi.org/10.2147/cia.s39120
Abstract
Peer reviewed article authored by (Flevari A, Theodorakopoulou M, Velegraki A, Armaganidis A, Dimopoulos G). Read article or submit your manuscript for publishing.Keywords
This publication has 87 references indexed in Scilit:
- Treatment of candidemia in adult patients without neutropenia - an inconvenient truthCritical Care, 2011
- Breakthrough Invasive Candidiasis in Patients on MicafunginJournal of Clinical Microbiology, 2010
- Echinocandin Susceptibility Testing ofCandidaSpecies: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest MediaAntimicrobial Agents and Chemotherapy, 2010
- In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of RareCandidaSpecies as Determined by CLSI Broth Microdilution MethodsJournal of Clinical Microbiology, 2009
- Discrepancies in reported drug use in geriatric outpatients: Relevance to adverse events and drug-drug interactionsThe American Journal of Geriatric Pharmacotherapy, 2009
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis , Candida orthopsilosis , and Candida metapsilosis Accounts for Reduced Echinocandin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global SurveillanceJournal of Clinical Microbiology, 2008
- Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related DifferencesAntimicrobial Agents and Chemotherapy, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006